Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -65.21%. However, over the past six months, we’ve seen a stronger performance of -59.51%. The price of DTIL leaped by -47.74% over the last 30 days. And in the last five days, it has fallen by -15.33%.
In terms of market performance, Precision Biosciences Inc had a fairly uneven. The highest value for the stock in the past year was $19.43 on 02/29/24, and the lowest value was recorded at $4.13 on 12/31/24.
52-week price history of DTIL Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Precision Biosciences Inc’s current trading price is -80.39% away from its 52-week high, while its distance from the 52-week low is -7.75%. The stock’s price range during this period has varied between$4.13 and $19.43. The Precision Biosciences Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.53 million for the day, a figure considerably higher than their average daily volume of 0.11 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Precision Biosciences Inc (DTIL) has experienced a quarterly decline of -58.13% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 29.23M and boasts a workforce of 109 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 8.14, with a change in price of -4.65. Similarly, Precision Biosciences Inc recorded 89,551 in trading volume during the last 100 days, posting a change of -54.96%.
DTIL’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for DTIL stands at 0.47. Similarly, the long-term debt-to-equity ratio is also 0.45.
DTIL Stock Stochastic Average
Precision Biosciences Inc’s raw stochastic average for the past 50 days is presently 3.58%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 6.12%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 8.74% and 12.26%, respectively.
